Pharmaceuticals APAC

APAC Exosome Therapeutics Market Analysis, 2024–2034

APAC Exosome Therapeutics Market Industry Trends and Forecast to 2034: Segmented by (Application, Source, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $52.1 Mn Estimated value
Estimate 2025 $65.6 Mn 21% of the global market
Projected 2034 $521.5 Mn 694.8% Adds $455.9 Mn over 9 forecast years
CAGR 2025–2034 25.9% Faster than 92% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • APAC is 21% of the global market.
  • Among regions, the largest is North America at $152.8 Mn.
  • Fastest growing: Africa at 26.6% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$455.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Exosome Therapeutics Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $52.1 Mn — —
2025 (base) $65.6 Mn +$13.5 Mn —
2026 (forecast) $82.6 Mn +$17.0 Mn +25.9%
2027 (forecast) $104.0 Mn +$21.4 Mn +58.5%
2028 (forecast) $131.0 Mn +$26.9 Mn +99.6%
2029 (forecast) $164.9 Mn +$33.9 Mn +151.2%
2030 (forecast) $207.6 Mn +$42.7 Mn +216.3%
2031 (forecast) $261.3 Mn +$53.8 Mn +298.2%
2032 (forecast) $329.0 Mn +$67.7 Mn +401.4%
2033 (forecast) $414.2 Mn +$85.2 Mn +531.3%
2034 (forecast) $521.5 Mn +$107.3 Mn +694.8%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $312.5 Mn
  2. North America $152.8 Mn
  3. US $138.3 Mn
  4. APAC (this report) $65.6 Mn
  5. Europe $59.7 Mn
  6. Canada $28.2 Mn
  7. China $26.9 Mn
  8. Japan $21.1 Mn
  9. Latin America $14.7 Mn
  10. Middle East $12.9 Mn
  11. Germany $12.1 Mn
  12. UK $8.2 Mn
  13. Brazil $7.7 Mn
  14. Italy $7.6 Mn
  15. France $7.2 Mn
  16. Spain $6.6 Mn
  17. Ecuador $5.5 Mn
  18. India $5.8 Mn
  19. Mexico $5.2 Mn
  20. Saudi Arabia $5.1 Mn
  21. Africa $4.2 Mn
  22. Australia $4.0 Mn
  23. New Zealand $3.7 Mn
  24. Russia $3.1 Mn
  25. South Africa $1.9 Mn
  26. UAE $1.6 Mn
  27. Egypt $1.0 Mn
  28. Malaysia $0.6 Mn
  29. Philippines $0.6 Mn
  30. Hong Kong $0.5 Mn
  31. Singapore $0.5 Mn
  32. Thailand $0.5 Mn
  33. Kenya $0.2 Mn

The APAC Exosome Therapeutics Market Analysis Executive Summary

Exosome therapeutics use tiny vesicles released by cells to carry drugs or healing signals, for cancer, inflammation and regenerative medicine.

Key segments of the exosome Therapeutics market include application (Drug Delivery, Regenerative Medicine and Diagnostics) and source (Stem Cell-Derived, Plant-Derived and Engineered).

APAC Exosome Therapeutics Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the exosome Therapeutics market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the exosome Therapeutics market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the exosome Therapeutics market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for Exosome Therapeutics Market in APAC

The exosome Therapeutics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Exosome Therapeutics Market in APAC

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for exosome Therapeutics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Exosome Therapeutics right now, from free public sources.

Clinical trials

46 active trials in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand, Bangladesh, Afghanistan, Indonesia, Myanmar, Nepal and Pakistan

Recruiting, about to start, or running now. Counted across the 16 countries we report on in APAC.

Top trial sponsors (worldwide)

  1. Biocells Medical 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 29 papers since 2021 (worldwide)

  1. Combination of kale-derived exosomes and dactolisib promotes apoptosis and modulates iron homeostasis in Hep3B hepatocellular carcinoma cells. Molecular biology reports, 2026
  2. Exosomal innovations in neurodegenerative disorders: Emerging insights and intranasal route. Biochemical and biophysical research communications, 2026
  3. An Innovative Strategy for Treating Neurodegenerative Disorders through Exosome-based Smart Delivery Systems: A Comprehensive Review. CNS & neurological disorders drug targets, 2026
  4. Biomaterial Engineering for Spatiotemporal Regulation of Exosome Functions: From Design Principles to Key Applications in Regenerative Medicine. Pharmaceuticals (Basel, Switzerland), 2026
  5. Engineering cardiac regeneration using stem cells: Cellular sources, differentiation signatures, targeted delivery, and functional recovery. Regenerative therapy, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Exosome Therapeutics in context

Questions, answered with public data

How many clinical trials on Exosome Therapeutics are running in APAC?
46 studies are recruiting, active or about to start in APAC, counted across the 16 countries we report on there.[1]
How much research is published on Exosome Therapeutics?
PubMed lists 29 papers added since January 2021 that match this market, worldwide.[2]

[1] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in APAC. Retrieved 12 Nov 2026.

[2] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Exosome Therapeutics in APAC? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Patient Support Programmes: Helping Patients Stay on TreatmentWHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient… Biologic Safety Testing: The Quiet Backbone of Drug MakingEvery vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches… Cell-Based Immunotherapy: Promise and PriceThe first CAR-T cell therapy was approved in the US in August 2017. These living drugs can work when other…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in APAC

See all
Same topic, other categories

Related on biologics and biosimilars and genomics

See the topic